Mesenchymal stromal stem cells (MSCs) possess a remarkable potential for numerous
clinical applications due to their unique properties including self-renewal …

Inflammatory bowel disease (IBD) is a major subtype of chronic enteropathies in dogs and
cats. Conventional drugs such as immunomodulatory medicines as glucocorticoids and/or …

Mesenchymal stromal cells (MSC) from adult bone marrow are the most commonly used
cells in clinical trials. MSCs from single donors are the preferred starting material but suffer …

Background Extracellular vesicles derived from mesenchymal stem cells (MSCs) show great
promise in treating osteoarthritis (OA). However, studies from the perspective of clinical …

Introduction The aim of this meta-analysis was to evaluate the efficacy and safety of
mesenchymal stem cells (MSCs) for the treatment of knee osteoarthritis (OA). Methods The …

Introduction Osteoarthritis (OA) related pain has affected millions of people worldwide.
However, the current pharmacological options for managing OA-related pain have not …

Background. Joint articular injection of mesenchymal stem cells (MSCs) has emerged as a
novel treatment approach for osteoarthritis (OA). However, the effectiveness of MSCs …

The knee, the most likely joint to present osteoarthritis (OA), is accountable for approximately
80% of the global burden of the OA [1, 2]. The prevalence of knee OA has continued to …

Background In knee osteoarthritis (KOA), treatments involving knee injections of bone
marrow-derived mesenchymal stem cells (BM-MSC), adipose tissue-derived mesenchymal …

Regenerative medicine-based therapies are considered promising for some chronic
diseases, such as osteoarthritis (OA). Because OA is the most common disease in many …